Christian Hölscher

13PUBLICATIONS
15CO-AUTHORS
Biomolecular modelling and designGlycoconjugatesPharmacogenomicsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 09, 2026
Semaglutide showed limited improvements in patients with Alzheimer's disease: Revisiting the evoke and evoke + clinical trials.

|Dec 01, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.

Paul Edison, Grazia Daniela Femminella, Craig Ritchie

|Sep 12, 2025
Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.

Christian Hölscher

|Jan 24, 2024
Liraglutide Reduces Alcohol Consumption, Anxiety, Memory Impairment, and Synapse Loss in Alcohol Dependent Mice.

Weizhen Liu, Ziliang Wang, Wang Wang

|Oct 04, 2023
A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson's Disease.

Zijuan Zhang, Ming Shi, Zhengmin Li

|Nov 24, 2022
DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model.

Lingyu Zhang, Chun Li, Zijuan Zhang

Pageof 3

Frequent Collaborators

1 joint publications

Bernadette McGuinness

1 joint publications

Patrick G Kehoe

1 joint publications

Stewart F Graham

1 joint publications

Xiao-Hui Wang